SELLAS Life Sciences Group, Inc. (SLS) Social Stream



SELLAS Life Sciences Group, Inc. (SLS): $3.31

0.19 (+6.09%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add SLS to Watchlist
Sign Up

Industry: Biotech


Ranked

of 392

in industry

Featured Post From StockTwits About SLS

$SLS Institutions Have been piling In! 30 days ago Fund ownership was 9.5% of SLS, its now 13% - Lots of new Positions, and funds Increasing Positions +30% 40% in their holdings. The GPS symposium may cause some significant Accumulation - it wouldn't take much from the Dr. Levy - Baylor Hematology Medical Director.

The Last AML Cr2 drug got bought for $1.5B when they published their Phase 3 Data - Gps P3 data is now only 4.5Months away ... not too long at all for 1,000%+ Gains and at some point this will begin stepping up from its puny .15b market cap.
4Roses, published August 16, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.426 seconds.